World's Best Scientists 2026 revealed!
Yannick Allanore

Yannick Allanore

D-Index & Metrics

Medicine

D-Index
106
Citations
52946
World Ranking
6410
National Ranking
186

Yannick Allanore publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Yannick Allanore sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 815 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Yannick Allanore D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Yannick Allanore sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Yannick Allanore is affiliated with Université Paris Cité in France. Their research primarily focuses on medicine, with a significant contribution in the fields of pathology and forensic medicine, pulmonary and respiratory medicine, rheumatology, epidemiology, and immunology.

The scientist's main topics of study encompass systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, inflammatory myopathies and dermatomyositis, dermatologic treatments and research, rheumatoid arthritis research and therapies, mast cells and histamine, and autoimmune bullous skin diseases.

Yannick Allanore has contributed to publications in numerous venues. Frequent publication outlets include:

  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Lara D. Veeken
  • The Lancet Rheumatology
  • Journal of Scleroderma and Related Disorders

Their collaboration network features several frequently co-authored researchers such as:

  • Jérôme Avouac
  • Oliver Distler
  • Marco Matucci-Cerinic
  • Christopher P. Denton
  • Dinesh Khanna

Among the recent papers associated with or relevant to their research area are:

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial (2020), The Lancet Respiratory Medicine
  • Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database (2020), Annals of the Rheumatic Diseases
  • COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study (2021), The Lancet Rheumatology
  • Methotrexate and rheumatoid arthritis associated interstitial lung disease (2020), European Respiratory Journal
  • Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients (2020), Annals of the Rheumatic Diseases

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

    Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier

  • Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

    Florence Tubach;Dominique Salmon;Philippe Ravaud;Yannick Allanore

  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies.

    Christophe Meune;Emmanuel Touzé;Ludovic Trinquart;Yannick Allanore

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

    Pierre-Antoine Juge;Joyce S Lee;Esther Ebstein;Hiroshi Furukawa

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies

    Muriel Elhai;Christophe Meune;Jérôme Avouac;André Kahan

  • Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Florian M P Meier;Klaus W Frommer;Robert Dinser;Ulrich A Walker

  • Prevalence of Pulmonary Hypertension in Systemic Sclerosis in European Caucasians and Metaanalysis of 5 Studies

    Jérôme Avouac;Paolo Airò;Christophe Meune;Lorenzo Beretta

  • High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

    Y. Allanore;D. Borderie;J. Avouac;D. Zerkak

  • Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

    Y. Allanore;C. Meune;M. C. Vonk;P. Airo

  • Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.

    Jacques-Eric Gottenberg;Florence Merle-Vincent;Fabrice Bentaberry;Yannick Allanore

Frequent Co-Authors

Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Oliver Distler
Oliver Distler University of Zurich
Christopher P. Denton
Christopher P. Denton University College London
Paolo Airò
Paolo Airò University of Brescia
Eric Hachulla
Eric Hachulla University of Lille
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Catherine Boileau
Catherine Boileau Université Paris Cité
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Luc Mouthon
Luc Mouthon Université Paris Cité
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA? There are many flexible, online options that can help you advance in the healthcare field without always requiring traditional, on-campus study.

For registered nurses, online rn-bsn programs without clinicals offer a seamless way to earn a bachelor’s degree while working, removing the need for additional clinical placements. If you’re looking to move into advanced practice or leadership, you might be interested in the shortest post master's dnp program options, which allow you to earn a Doctor of Nursing Practice in less time.

There are also dnp online programs available that offer accelerated coursework and flexible schedules, making them accessible for busy professionals. For those aiming to start their nursing journey as quickly as possible, a 9 month lpn program can fast-track entry into the healthcare workforce.

These online pathways make it easier than ever to upskill and find your place in the dynamic world of medicine—on your schedule and at your pace.

Best Scientists Citing Yannick Allanore

Trending Scientists